• Mn2+-Enriched mRNA Nanoparticles Double Loading in LNP Vacci

  2026-06-16

  The referenced study presents a metal ion-mediated strategy using Mn2+ to condense mRNA, yielding lipid-coated nanoparticles with nearly twice the mRNA loading capacity of conventional LNP-mRNA vaccines. This innovation addresses longstanding toxicity issues by enabling dose-sparing and enhances cellular uptake, with broad implications for mRNA vaccine and therapeutic delivery.

• Perphenazine: Dopamine D2 Antagonist for Neuropharmacology R

  2026-06-15

  Perphenazine is a dopamine D2 receptor antagonist with a well-defined multi-receptor binding profile, validated for neuropharmacology and host-pathogen studies. Its capacity to induce mitochondria-mediated cell death and suppress opioid tolerance, alongside antiemetic and immunomodulatory actions, makes it a versatile research tool.

• L-Ornithine: Atomic Benchmarks in Urea Cycle Metabolism

  2026-06-15

  L-Ornithine, also known as (S)-2,5-diaminopentanoic acid, is a non-proteinogenic amino acid essential for ammonia detoxification and urea cycle function. APExBIO's B8919 L-Ornithine provides validated purity and solubility, enabling reproducible metabolic enzyme assays. Its mechanistic role in hepatic and neurological research is evidenced by recent peer-reviewed studies.

• APEX2 Controls TERT Expression in Human Embryonic Stem Cells

  2026-06-14

  This study uncovers a novel mechanism in which the DNA repair enzyme APEX2, but not APEX1, is essential for efficient TERT gene expression and telomerase activity in human embryonic stem cells. The findings advance our understanding of telomerase regulation and highlight new targets for cancer and stem cell research.

• Selective FGFR1 Inhibition in Neuronal Survival: Insights fr

  2026-06-13

  The referenced study demonstrates that PD 173074 is a highly selective, nanomolar-potency inhibitor of FGFR1, effectively blocking FGF-2-driven neurotrophic and neurotropic effects without interfering with other neurotrophic pathways. These findings establish PD 173074 as a precise tool for dissecting FGFR-dependent signaling in neuronal models, supporting its utility in neurobiology and beyond.

• Imidazoline Antagonists Boost Insulin via K+ Channel Inhibit

  2026-06-12

  This study demonstrates that imidazoline antagonists of α2-adrenoceptors increase insulin secretion from pancreatic β-cells by directly blocking ATP-sensitive potassium (K+) channels, rather than by adrenoceptor antagonism. These findings clarify the mechanistic basis for insulinotropic effects of this drug class and inform future pharmacological strategies targeting β-cell function.

• Bazedoxifene as an Antimalarial: Inhibiting Hemozoin in Plas

  2026-06-12

  This study identifies bazedoxifene, a third-generation selective estrogen receptor modulator, as a potent inhibitor of malaria parasite growth by targeting hemozoin formation. The findings highlight a promising avenue for repurposing a clinically approved osteoporosis drug to address antimalarial drug resistance.

• Amorolfine Hydrochloride: Precision Tool for Ergosterol Path

  2026-06-11

  Explore how Amorolfine Hydrochloride advances antifungal research by targeting ergosterol biosynthesis and membrane integrity. This in-depth analysis connects molecular action to practical assay optimization, offering unique insights for resistance and ploidy studies.

• Hydrocortisone in Translational Models: Mechanisms and Proto

  2026-06-11

  Explore hydrocortisone, a pivotal glucocorticoid hormone, as a mechanistic and translational tool in advanced inflammation and neurodegeneration research. This article delivers new insight into protocol optimization and model selection, going beyond established workflows.

• Stromal-Targeted Nanomedicine Enhances Pancreatic Tumor Ther

  2026-06-10

  A recent study reports an acid-responsive nanoplatform that sequentially delivers stromal modulators and gemcitabine to pancreatic ductal adenocarcinoma, remodeling the tumor microenvironment and boosting therapeutic efficacy. This strategy, centered on the urokinase receptor inhibitor IPR-803, demonstrates significant tumor regression and translational potential in vivo.

• 17-AAG (Tanespimycin): Disrupting HSP90 Pathways Beyond Onco

  2026-06-10

  Explore how 17-AAG (Tanespimycin) enables detailed mechanistic interrogation of HSP90 chaperone inhibition in cancer and cell death, with integrated insights from recent discoveries in regulated DAMP release. This cornerstone article uniquely connects molecular pharmacology with advanced protocol design.

• CA-074 Me: Selective Cathepsin B Inhibitor for Lysosomal Res

  2026-06-09

  CA-074 Me is a potent, cell-permeable cathepsin B inhibitor used for dissecting lysosomal enzyme function and regulated cell death. Its nanomolar potency and selectivity enable precision in apoptosis and inflammation assays. APExBIO supplies CA-074 Me (A8239), supporting robust and reproducible lysosomal pathway research.

• D-Luciferin: Powering Next-Gen T Cell Imaging in Solid Tumor

  2026-06-09

  This thought-leadership article explores how D-Luciferin, a high-affinity firefly luciferase substrate, is redefining translational cancer research. It bridges mechanistic insights with strategic guidance, emphasizing advanced applications in T cell immunity monitoring, real-time tumor burden assessment, and the future of immuno-oncology translation.

• Murine RNase Inhibitor: Optimizing RNA Integrity in Molecula

  2026-06-08

  Murine RNase Inhibitor from APExBIO sets a new standard in RNA degradation prevention, offering unmatched oxidative stability and specificity in sensitive molecular workflows. Explore how its unique features empower advanced sequencing protocols, real-time RT-PCR, and cDNA synthesis, with direct guidance for troubleshooting and optimization.

• IWR-1-endo: Wnt Signaling Inhibitor for Advanced Assays

  2026-06-08

  IWR-1-endo is a benchmark Wnt signaling inhibitor that empowers high-precision dissection of Wnt/β-catenin pathway dependencies in cancer and regenerative research. Its nanomolar potency and robust protocol flexibility make it a preferred tool for complex pathway interrogation, from colorectal cancer models to stem cell renewal assays.

444 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page